Guide for Lung Cancer Gene Tests Published (CME/CE)

(MedPage Today) -- All patients with advanced lung adenocarcinoma should undergo testing for EGFR and ALK mutations to determine their eligibility for targeted therapies, according to jointly developed recommendations from three organizations.
Source: MedPage Today Pulmonary - Category: Respiratory Medicine Source Type: news